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Abstract Wilson’s disease, an autosomal recessive disorder, is
characterized by the excessive accumulation of hepatic copper
that results from reduced biliary copper excretion and disturbed
incorporation of copper into ceruloplasmin. The ATP7B gene,
responsible for the disease, encodes a copper transporting P-type
ATPase. We previously demonstrated the involvement of ATP7B
in hepatic copper secretion into plasma after the introduction of
ATP7B into the Long-Evans Cinnamon (LEC) rat, a rodent
model of Wilson’s disease. In this study we found the increased
copper contents of the hepatic lysosomal fractions and bile in the
LEC rats after ATP7B introduction, indicating the participation
of ATP7B in the biliary excretory pathway for copper.
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1. Introduction
Although copper is an essential trace metal, copper in ex-
cess of cellular needs is toxic [1]. Patients with Wilson’s dis-
ease and its rodent model, the Long-Evans Cinnamon (LEC)
rat, are characterized by the excessive accumulation of hepatic
copper and manifest similar pathologic features including the
reduced biliary excretion of copper, reduced copper in plasma
and a remarkable decrease of serum ceruloplasmin (CPN)
oxidase activity [2^4]. The genes responsible for Wilson’s dis-
ease and the LEC rat have been designated ATP7B (previ-
ously designated WND) and atp7b, respectively (for review see
[5]). The abnormal copper metabolism in the a¡ected liver is
believed to be due to mutations of these genes. Indeed, nu-
merous mutations including point mutations, deletions,
frame-shifts and splice errors have been reported in the pa-
tients with Wilson’s disease [6]. In the LEC rat, atp7b is
known to be deleted at its 3P end [7] and its expression is
absent [8].
ATP7B or Atp7b is predicted to be a copper transporting
P-type ATPase from the deduced amino acid sequence. P-type
ATPase is phosphorylated at their aspartic acid residue in the
DKTGT/S motif and translocates a variety of cations across
membranes [9]. Among P-type ATPases, ATP7B or Atp7b is
further classi¢ed as a heavy metal transporting P-type ATPase
that pumps copper or cadmium [10,11]. The characteristic
features of ATP7B are six metal binding motifs, GMTCXXC,
at the N-terminus of the molecule (¢ve motifs in Atp7b), the
CPC motif in the sixth transmembrane region, the SEHPL
motif and eight transmembrane segments. The metal binding
motifs are speci¢c for copper and 1 mol of the N-terminus
containing six binding motifs of the protein binds to 6 mol of
copper [12]. The CPC motif and the SEHPL motif, as well as
the metal binding region, in ATP7B are critical for copper
transport by this protein [13^15].
Major export pathways for copper from hepatocytes in-
clude its secretion into plasma following its incorporation
into CPN and its excretion into bile. ATP7B is thought to
play an important role in these processes. The importance of
ATP7B in the intracellular transport of copper is supported
by recent studies using a yeast strain lacking CCC2, the yeast
homologue of ATP7B [13,14]. These studies have revealed
that ATP7B is able to complement the function of CCC2.
An in vitro study using a murine ¢broblast cell line carrying
defective Atp7a, another mammalian copper transporting P-
type ATPase, has shown that ATP7B substitutes Atp7a func-
tion in copper export [15]. We recently demonstrated the re-
stored secretion of holoCPN, oxidase active and copper
bound form, following the introduction of ATP7B into the
LEC rat by recombinant adenovirus mediated gene delivery
[16]. This indicates that ATP7B functions in copper secretion
into plasma, however, the role of ATP7B in the biliary excre-
tion of copper has not been directly demonstrated.
In this study, we introduced ATP7B into the LEC rat by
recombinant adenovirus mediated gene delivery and examined
ATP7B function with respect to the biliary excretory pathway
for copper.
2. Materials and methods
2.1. Animal studies
Inbred LEC rats were bred under speci¢c pathogen-free conditions
in the Animal Facilities for Experimental Medicine, Akita University
School of Medicine. Animals had free access to water and standard
rat chow. All experiments were performed in accordance with the
animal guidelines of Akita University School of Medicine. Recombi-
nant adenoviruses bearing full-length ATP7B cDNA, designated
AxCAWD, were prepared as described previously [16]. 1U1010 plaque
forming unit (pfu) of AxCAWD, or control virus AxCAwt, were
administered to six or 11 week old LEC rats by tail vein injection.
Blood was collected from the carotid vein before and 3 days after viral
infusion. Plasma was stored at 380‡C until use. Bile was collected
3 days after infusion in the following manner. Animals were anesthe-
tized with sodium pentobarbital (50 mg/kg body weight) and the bile
duct was cannulated with polyethylene tube (PE-10, Igarashi, Tokyo).
Liver was removed 3 days after infusion and weighed prior to homog-
enization.
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2.2. Preparation of subcellular fractions
The subcellular fractions of liver were obtained from the LEC rat
infused with recombinant adenoviruses. The procedures described be-
low were performed at 4‡C. The liver was minced and homogenized in
3 volumes (w/v) of SHE bu¡er (0.25 M sucrose/10 mM HEPES-
NaOH, pH 7.2/1 mM EDTA) using a Potter-Elvehjem homogenizer
with a Te£on pestle at 1000 rpm for ¢ve strokes. The homogenate was
centrifuged for 10 min at 600Ug, and the resulting supernatant was
saved as postnuclear supernatant. The postnuclear supernatant was
centrifuged for 10 min at 5000Ug, and the supernatant was recentri-
fuged for 10 min at 25 000Ug. The lysosomal fraction was prepared
from the 25 000Ug pellet by Percoll gradient centrifugation as de-
scribed previously [16]. The 25 000Ug supernatant was centrifuged
for 1 h at 140 000Ug and the resulting supernatant and pellet were
saved as cytosol and microsomal fraction, respectively. The pellet
containing the microsomal fraction was suspended in SHE bu¡er
and homogenized with a Te£on pestle by hand. Enrichment of the
lysosomal fraction was con¢rmed by immunodetection using antibod-
ies against human cathepsin D (Upstate Biotechnology, Lake Placid,
NY).
2.3. Western blot analysis
The protein samples were resolved by polyacrylamide gel electro-
phoresis (PAGE) under denaturing or non-denaturing conditions, and
immunodetection was performed by Western blot analysis as de-
scribed [17]. Antibodies against ATP7B and CPN were prepared as
described previously [16].
2.4. Measurement of copper content
The copper contents in the subcellular fractions and bile were meas-
ured directly by atomic absorption spectroscopy using a polarized
Zeeman atomic absorption spectrophotometer (Model 180-80, Hita-
chi, Japan) equipped with graphite furnace.
3. Results
3.1. Copper accumulation in lysosomal fractions of LEC rat
livers after adenoviral infusion
To determine the intracellular distribution of copper after
the introduction of ATP7B, the subcellular fractions of liver
were prepared from the LEC rats 3 days after infusion of
AxCAWD or control virus. As shown in Table 1, the mean
value of lysosomal copper contents obtained from the two
rats with introduced ATP7B was 10.5-fold higher than that
of two controls (1.68 Wg/g wet liver vs. 0.16 Wg/g wet liver),
whereas the mean value of cytosolic copper contents in these
rats was reduced to 32% of the controls (23.4 Wg/g wet liver
vs. 73.2 Wg/g wet liver). The enrichment of the lysosomal
fraction was con¢rmed by the immunoblotting using the anti-
body against cathepsin D known as a lysosomal marker (Fig.
1, lower panel). In the rats in which ATP7B was introduced,
the accumulated copper in the lysosomal fraction seems not to
be sequestered in association with this protein in this organ-
elle, since ATP7B is not detected in this fraction, but in the
microsomal fraction which contains Golgi apparatus (Fig. 1,
upper panel), the site where ATP7B resides [13,16,18].
3.2. Increased excretion of copper into bile after adenoviral
infusion
To investigate ATP7B function with respect to the func-
tional biliary excretory pathway for copper, copper contents
in bile collected from the LEC rats 3 days after viral infusion
were determined. Since the bile duct in the LEC rat less than
200 g of body weight is thin compared to the normal rat, 11-
week-old LEC rats (250 g of body weight) were used. As
shown in Fig. 2, the two LEC rats with introduced ATP7B
showed 2.4-fold increase of biliary copper content relative to
the two controls (the mean values are 2.63 ng/min vs. 1.10 ng/
min). The holoCPN secretion into plasma in these two rats
with introduced ATP7B was con¢rmed by the immunodetec-
tion (Fig. 3, upper panel), is consistent with our recent study
[16]. No holoCPN was secreted in the two control rats (Fig. 3,
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Table 1
Copper distribution in the subcellular fractions of livers from the LEC rats after infusion of the recombinant adenovirus
Cu (Wg/g wet liver)
PNS Microsome Lysosome Cystosol
+wt-1 114.1 2.2 0.14 75.5
+wt-2 101.3 1.8 0.18 70.9
(Mean) (107.7) (2.2) (0.16) (73.2)
+ATB7B-1 61.4 0.34 1.25 27.4
+ATB7B-2 61.6 0.58 2.10 18.9
(Mean) (61.5) (0.46) (1.68) (23.4)
Copper distribution in the subcellular fractions of livers from the LEC rats after infusion of the recombinant adenovirus. Four 6-week-old LEC rats
were infused with 1U1010 pfu of either AxCAWD (+ATP7B-1, +ATP7B-2) or AxCAwt (+wt-1, +wt-2), the control virus. The subcellular fractions
were prepared freshly from the rat livers 3 days after infusion as described in Section 2. The copper contents (Wg/g wet liver) in the subcellular
fractions were determined by atomic absorption spectrophotometry. PNS, postnuclear supernatants. The mean value of each fraction from two rats
is also shown.
Fig. 1. Expression of ATP7B in the subcellular fractions of livers
from the LEC rats after infusion of the recombinant adenovirus.
Western blot analysis of equivalent amounts of protein samples (5
Wg) obtained from the subcellular fractions of the LEC rat livers
after infusion with either AxCAWD (+ATP7B, lanes 1^4) or Ax-
CAwt (+wt, lanes 5^8). The subcellular fractions were identical to
those used in Table 1. The protein samples were subjected to 7%
SDS-PAGE and transferred to a PVDF membrane. The blot was
probed with anti-ATP7B monoclonal antibody (1:200, upper panel),
and anti-human cathepsin D polyclonal antibody (1:200, lower pan-
el). Bound antibodies were detected by chemiluminescence. Lanes 1
and 5, post nuclear supernatants (PNS); lanes 2 and 6, microsomal
fractions (ms). Lanes 3 and 7, lysosomal fractions (lys). Lanes 4
and 8, cytosol (cyt). A representative experiment is shown.
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lower panel). These results indicate that the biliary excretion
of copper and the secretion of copper were restored in the
LEC rats after the introduction of ATP7B.
4. Discussion
In the present study we demonstrated the restoration of
biliary copper excretion in the LEC rats after the introduction
of human ATP7B cDNA using the recombinant adenovirus.
The major export pathways for hepatic copper consist of
the secretion into plasma following its incorporation into
CPN and the excretion into bile. Since ATP7B is predicted
to be a copper transporting P-type ATPase from its amino
acid sequence, ATP7B is suggested to play an important role
in these processes. Indeed, our recent study has revealed that
ATP7B is involved in the secretion of copper coupled with
CPN synthesis [16], although the association of ATP7B with
the biliary export pathway for copper was only indirectly
demonstrated [19]. To resolve this problem, we examined
the intracellular distribution of copper and the recovery of
biliary excretion of copper in the LEC rats after the introduc-
tion of ATP7B. Consequently, we found the decrease of cy-
tosolic copper, the elevated levels of copper content in the
lysosomal fractions and the increased biliary excretion of cop-
per in the LEC rats infused with AxCAWD, not with control
viruses. The cytosolic copper was probably reduced by its
discharge into bile through the lysosomal fractions. These in-
dicate that ATP7B functions in the excretory pathway for
copper, as well as in the secretory pathway. These data are
consistent with prior studies on experimental copper overload
states in rat liver [20] and studies on Wilson’s disease patients
[21] suggesting that lysosomes were the sites for storage of
copper and the main source of biliary copper. Additionally,
evidence that biliary excretion of copper was inhibited by a
microtubule inhibitor, colchicine, indicated the involvement of
vesicular transport in the biliary copper export [22]. Based on
these data and observations that ATP7B localizes to the Golgi
apparatus in hepatocytes [13,16,18], we hypothesize that the
excretory route for copper from hepatocytes is as follows:
cytosolic copper taken up into the Golgi apparatus by
ATP7B is transported to lysosomes by vesicular transport.
Subsequently, copper in lysosomes is released into bile by
exocytosis. Since the LEC rat exhibits the spontaneous accu-
mulation of copper in the liver, resembling experimental cop-
per overload states, a considerable amount of copper seems to
be transported through the lysosomal-biliary pathway after
the induction of ATP7B.
The requirement of ATP7B in hepatic copper transport ex-
plains the pathogenesis of Wilson’s disease. Patients with the
disease have a defect in ATP7B, leading to a disturbance of
intracellular copper transport. Among numerous mutations of
ATP7B reported in the patients, mutations of H1069Q or
N1270S were shown to lose their copper transport function
in vitro studies [13^15]. In addition, mutations introduced into
the critical sites in ATP7B, such as the DKTGT/S motif and
the CPC motif, were also found to alter the copper transport
function of ATP7B [13,14]. These observations imply that
intact ATP7B is necessary to regulate copper homeostasis in
the liver. In the intracellular tra⁄cking of copper, ATP7B
may act as a gate which controls the copper £ow through
the secretory and excretory pathways in liver.
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Fig. 3. Detection of holoceruloplasmin in plasma of the LEC rats
after infusion of the recombinant adenoviruses. Western blot show-
ing the chemiluminescent detection of ceruloplasmin in plasma of
the LEC rats. Plasma samples were obtained from four 11-week-old
LEC rats infused with 1U1010 pfu of either AxCAWD (upper pan-
el, +ATP7B (1 and 2) or AxCAwt, the control virus (lower panel,
+wt (1 and 2). The samples were subjected to 7% PAGE under
non-denaturing conditions and transferred to PVDF membranes.
The blots were probed with anti-rat ceruloplasmin antibodies
(1:1000). Lane 1, plasma from Sprague-Dawley (SD) rat. Lanes 2
and 4, plasma from LEC rats before viral infusion. Lanes 3 and 5,
plasma from LEC rats 3 days after viral infusion. Plasma taken
from the SD rat and the LEC rats were diluted to 1:500 and 1:100,
respectively, and 10 Wl of each was applied. Plasma from the SD rat
was applied to show the mobility of holoceruloplasmin on PAGE
under non-denaturing conditions.
Fig. 2. Copper contents in bile obtained from the LEC rats after in-
fusion of the recombinant adenovirus. Bile samples were obtained
from four 11-week-old LEC rats infused with 1U1010 pfu of re-
combinant viruses. The two LEC rats were infused with AxCAWD
(+ATP7B), and the other two with AxCAwt (+wt), the control vi-
rus. The samples were collected 3 days after viral infusion. The cop-
per contents were determined by atomic absorption spectrophotome-
try. The mean value of each group of rats is shown.
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